Sales decline 16.37% to Rs 10.93 crore
Net loss of Bafna Pharmaceuticals reported to Rs 22.33 crore in the quarter ended December 2019 as against net profit of Rs 0.06 crore during the previous quarter ended December 2018. Sales declined 16.37% to Rs 10.93 crore in the quarter ended December 2019 as against Rs 13.07 crore during the previous quarter ended December 2018. ParticularsQuarter EndedDec. 2019Dec. 2018% Var.Sales10.9313.07 -16 OPM %2.018.88 -PBDT0.351.01 -65 PBT-0.650.11 PL NP-22.330.06 PLPowered by Capital Market - Live News